metabolic health

Glucomannan Lipid Markers Meta-Analysis Evidence Table

Name: Glucomannan Lipid Markers Meta-Analysis Evidence Table
Creator: Migaku

Structured evidence table for Glucomannan Lipid Markers Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.

topic	claim	evidence level	citation	source
Glucomannan Lipid Markers Meta-Analysis	The primary therapeutic objective of T2DM management is to achieve optimal glycemic control while mitigating the risk factors of cardiovascular diseases, thereby reducing the likelihood of developing diabetes-related complications ().	2	Dehzad Mohammad Jafar (2025)	Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Glucomannan Lipid Markers Meta-Analysis	Low-fat dairy products, particularly yogurt, have been consistently associated with a reduced risk of developing and improved management of T2DM (;;).	2	Dehzad Mohammad Jafar (2025)	Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Glucomannan Lipid Markers Meta-Analysis	These factors contribute to improved glucose control, insulin sensitivity, and weight management ().	2	Dehzad Mohammad Jafar (2025)	Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Glucomannan Lipid Markers Meta-Analysis	Galicia-Garcia et al., 2020 Jenkins et al., 2018 Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder that results from impaired insulin secretion by pancreatic β-cells and decreased insulin sensitivity in target tissues ().	2	Dehzad Mohammad Jafar (2025)	Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

topicGlucomannan Lipid Markers Meta-Analysis

claimThe primary therapeutic objective of T2DM management is to achieve optimal glycemic control while mitigating the risk factors of cardiovascular diseases, thereby reducing the likelihood of developing diabetes-related complications ().

evidence level2

citationDehzad Mohammad Jafar (2025)

sourceEffects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

topicGlucomannan Lipid Markers Meta-Analysis

claimLow-fat dairy products, particularly yogurt, have been consistently associated with a reduced risk of developing and improved management of T2DM (;;).

evidence level2

citationDehzad Mohammad Jafar (2025)

topicGlucomannan Lipid Markers Meta-Analysis

claimThese factors contribute to improved glucose control, insulin sensitivity, and weight management ().

evidence level2

citationDehzad Mohammad Jafar (2025)

topicGlucomannan Lipid Markers Meta-Analysis

claimGalicia-Garcia et al., 2020 Jenkins et al., 2018 Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder that results from impaired insulin secretion by pancreatic β-cells and decreased insulin sensitivity in target tissues ().

evidence level2

citationDehzad Mohammad Jafar (2025)

Source documents

Effects of Yogurt Enriched with Konjac Glucomannan and Inulin on Insulin Sensitivity, Glycemic Control, Lipid Profiles, Anthropometric Measures and Oxidative Stress in Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Glucomannan Lipid Markers Meta-Analysis Evidence Table

Related evidence and supplement guides